Brief: Solid Biosciences Announces Stockholder Approval Of Acquisition Of Aavantibio
01/12/2022 21:40
Dec 1 (Reuters) - Solid Biosciences Inc SLDB.O :
* SOLID BIOSCIENCES ANNOUNCES STOCKHOLDER APPROVAL OF
ACQUISITION
OF AAVANTIBIO
* TRANSACTIONS TO CREATE A PRECISION GENETIC MEDICINE
COMPANY
FOCUSED ON NEUROMUSCULAR AND CARDIAC RARE DISEASES
Source text for Eikon: ID:nGNX4gqPvF
Further company coverage: SLDB.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Solid Biosciences
See all newsMarketing Agreement To Advance Gene Therapy Delivery And Analytics
Solid Biosciences Q1 net loss widens on higher R&D costs
Solid Biosciences Q4 net loss widens on higher R&D costs
NASDAQ RESUMED AT 01:58 PM
Brief: Solid Biosciences Provides Interim Positive Clinical Update On Phase 1/2 Inspire Duchenne Trial